vs
Side-by-side financial comparison of IDEAYA Biosciences, Inc. (IDYA) and MOVADO GROUP INC (MOV). Click either name above to swap in a different company.
IDEAYA Biosciences, Inc. is the larger business by last-quarter revenue ($207.8M vs $186.1M, roughly 1.1× MOVADO GROUP INC). IDEAYA Biosciences, Inc. runs the higher net margin — 57.4% vs 5.1%, a 52.2% gap on every dollar of revenue. IDEAYA Biosciences, Inc. produced more free cash flow last quarter ($142.2M vs $11.6M).
IDEAYA Biosciences, Inc. is a clinical-stage biotechnology company focused on oncology, developing targeted therapies and synthetic lethality treatments for patients with genetically defined cancers. It advances a pipeline of candidates across multiple tumor types, partnering with industry stakeholders to accelerate global access to innovative cancer care solutions.
Movado is a luxury American watch brand originally founded in 1881 in Switzerland. Movado means "movement" in Esperanto. The watches are known for their signature metallic dot at 12 o'clock and minimalist style; the company is best known for its Museum Watch.
IDYA vs MOV — Head-to-Head
Income Statement — Q3 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $207.8M | $186.1M |
| Net Profit | $119.2M | $9.6M |
| Gross Margin | — | 54.3% |
| Operating Margin | 52.2% | 6.3% |
| Net Margin | 57.4% | 5.1% |
| Revenue YoY | — | 1.9% |
| Net Profit YoY | 330.1% | 89.8% |
| EPS (diluted) | $1.33 | $0.42 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $186.1M | ||
| Q3 25 | $207.8M | $161.8M | ||
| Q2 25 | — | $131.8M | ||
| Q1 25 | — | $181.5M | ||
| Q4 24 | — | $180.5M | ||
| Q3 24 | $0 | $157.0M | ||
| Q2 24 | $0 | $134.4M | ||
| Q1 24 | $0 | $175.8M |
| Q4 25 | — | $9.6M | ||
| Q3 25 | $119.2M | $3.0M | ||
| Q2 25 | — | $1.4M | ||
| Q1 25 | — | $8.1M | ||
| Q4 24 | — | $4.8M | ||
| Q3 24 | $-51.8M | $3.5M | ||
| Q2 24 | $-52.8M | $2.0M | ||
| Q1 24 | $-39.6M | $9.8M |
| Q4 25 | — | 54.3% | ||
| Q3 25 | — | 54.1% | ||
| Q2 25 | — | 54.1% | ||
| Q1 25 | — | 54.2% | ||
| Q4 24 | — | 53.5% | ||
| Q3 24 | — | 54.3% | ||
| Q2 24 | — | 54.3% | ||
| Q1 24 | — | 53.5% |
| Q4 25 | — | 6.3% | ||
| Q3 25 | 52.2% | 2.5% | ||
| Q2 25 | — | 0.2% | ||
| Q1 25 | — | 5.1% | ||
| Q4 24 | — | 3.3% | ||
| Q3 24 | — | 1.7% | ||
| Q2 24 | — | 1.6% | ||
| Q1 24 | — | 6.1% |
| Q4 25 | — | 5.1% | ||
| Q3 25 | 57.4% | 1.8% | ||
| Q2 25 | — | 1.1% | ||
| Q1 25 | — | 4.4% | ||
| Q4 24 | — | 2.7% | ||
| Q3 24 | — | 2.2% | ||
| Q2 24 | — | 1.5% | ||
| Q1 24 | — | 5.6% |
| Q4 25 | — | $0.42 | ||
| Q3 25 | $1.33 | $0.13 | ||
| Q2 25 | — | $0.06 | ||
| Q1 25 | — | $0.36 | ||
| Q4 24 | — | $0.21 | ||
| Q3 24 | $-0.60 | $0.15 | ||
| Q2 24 | $-0.68 | $0.09 | ||
| Q1 24 | $-0.53 | $0.44 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $786.9M | $183.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.1B | $497.5M |
| Total Assets | $1.2B | $751.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $183.9M | ||
| Q3 25 | $786.9M | $180.5M | ||
| Q2 25 | — | $203.1M | ||
| Q1 25 | — | $208.5M | ||
| Q4 24 | — | $181.5M | ||
| Q3 24 | $920.0M | $198.3M | ||
| Q2 24 | $701.7M | $225.4M | ||
| Q1 24 | $698.8M | $262.1M |
| Q4 25 | — | $497.5M | ||
| Q3 25 | $1.1B | $489.9M | ||
| Q2 25 | — | $493.2M | ||
| Q1 25 | — | $481.3M | ||
| Q4 24 | — | $491.3M | ||
| Q3 24 | $1.2B | $492.0M | ||
| Q2 24 | $931.7M | $489.6M | ||
| Q1 24 | $935.3M | $505.9M |
| Q4 25 | — | $751.9M | ||
| Q3 25 | $1.2B | $748.7M | ||
| Q2 25 | — | $747.2M | ||
| Q1 25 | — | $729.2M | ||
| Q4 24 | — | $747.2M | ||
| Q3 24 | $1.2B | $742.5M | ||
| Q2 24 | $973.7M | $736.0M | ||
| Q1 24 | $961.5M | $756.5M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $142.2M | $12.3M |
| Free Cash FlowOCF − Capex | $142.2M | $11.6M |
| FCF MarginFCF / Revenue | 68.4% | 6.2% |
| Capex IntensityCapex / Revenue | 0.0% | 0.4% |
| Cash ConversionOCF / Net Profit | 1.19× | 1.28× |
| TTM Free Cash FlowTrailing 4 quarters | $13.5M | $35.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $12.3M | ||
| Q3 25 | $142.2M | $-3.8M | ||
| Q2 25 | — | $-7.2M | ||
| Q1 25 | — | $39.1M | ||
| Q4 24 | — | $-4.7M | ||
| Q3 24 | $-49.2M | $-17.8M | ||
| Q2 24 | $-32.9M | $-18.1M | ||
| Q1 24 | $-43.8M | $69.4M |
| Q4 25 | — | $11.6M | ||
| Q3 25 | $142.2M | $-5.1M | ||
| Q2 25 | — | $-8.7M | ||
| Q1 25 | — | $37.5M | ||
| Q4 24 | — | $-7.2M | ||
| Q3 24 | $-49.7M | $-20.1M | ||
| Q2 24 | $-33.9M | $-19.7M | ||
| Q1 24 | $-45.1M | $67.8M |
| Q4 25 | — | 6.2% | ||
| Q3 25 | 68.4% | -3.1% | ||
| Q2 25 | — | -6.6% | ||
| Q1 25 | — | 20.7% | ||
| Q4 24 | — | -4.0% | ||
| Q3 24 | — | -12.8% | ||
| Q2 24 | — | -14.7% | ||
| Q1 24 | — | 38.6% |
| Q4 25 | — | 0.4% | ||
| Q3 25 | 0.0% | 0.8% | ||
| Q2 25 | — | 1.2% | ||
| Q1 25 | — | 0.9% | ||
| Q4 24 | — | 1.4% | ||
| Q3 24 | — | 1.5% | ||
| Q2 24 | — | 1.2% | ||
| Q1 24 | — | 0.9% |
| Q4 25 | — | 1.28× | ||
| Q3 25 | 1.19× | -1.27× | ||
| Q2 25 | — | -5.08× | ||
| Q1 25 | — | 4.86× | ||
| Q4 24 | — | -0.98× | ||
| Q3 24 | — | -5.14× | ||
| Q2 24 | — | -8.97× | ||
| Q1 24 | — | 7.06× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IDYA
Segment breakdown not available.
MOV
| Other | $81.4M | 44% |
| Owned Brands Category | $46.0M | 25% |
| Sales Channel Directly To Consumer | $35.3M | 19% |
| Company Stores | $23.4M | 13% |
